Trial Information
Observational Study on Surgical Treatment of Early Stage (T1-T2) Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance
Inclusion Criteria:
- The subject has signed consent
- The subject must be a member or beneficiary of a health insurance plan
- The patient is available for 12 months of follow-up
- The subject has a cancer of the larynx:
- classified T1 or T2 in the TNM
- glottic localization and / or supraglottic regardless of node status
- with or without a history of head and neck cancer
- The subject does not have distant metastasis (M0)
- A decision for endoscopic robot-assisted surgery is retained in multidisciplinary
meeting
Exclusion Criteria:
-
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The presence/absence of cancerous tissue in the surgical margins of the resectioned tumors
Outcome Time Frame:
1 day
Safety Issue:
No
Principal Investigator
Benjamin Lallemant, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Centre Hospitalier Universitaire de Nîmes
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
AOI/2010/BL-01
NCT ID:
NCT01257633
Start Date:
April 2011
Completion Date:
February 2015
Related Keywords:
- Laryngeal Neoplasms
- da Vinci surgical robot
- laryngeal cancer
- Neoplasms
- Laryngeal Neoplasms